Join experts Rebecca Miksad and Tim Stoddard of Flatiron Health for a practical look at the role of real-world evidence (RWE) in regulatory, drug development, and clinical decision-making. This area has been rapidly expanding in its applications, prompting FDA’s development of a framework for evaluating the potential use of RWE in regulatory settings.
Given the growing importance of RWE, clinical trial and drug development professionals need to understand the sources of real-world data (RWD), potential uses of RWE, as well as the limitations and strengths of each approach. This free webinar will describe the current state of RWE science and provide context for the regulatory and research implications of RWD and RWE.
Rebecca Miksad MD, MPH
Senior Medical Director, Flatiron Health
Senior Director, Quality & Regulatory Solutions, Flatiron Health
Who Should Watch?
The content of the regulatory-grade RWE webinar applies to all researchers and staff involved with design, conduct, coordination, monitoring, and interpretation of clinical research. For example, clinical trial sites (institutions as well as unaffiliated sites), sponsors, regulatory groups, CROs, and other research organizations. This topic is of special interest to regulatory stakeholders.
The presentation may qualify for continuing education credits; check with your certifying organization(s) for more information.
Tuesday, May 14, or Thursday, May 16
(1:00 p.m. ET | 10:00 a.m. PT)